Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial-Reference-Cited by-同舟云学术

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: Analysis of the CALYPSO trial

Published:2015-01 Issue:1 Volume:136 Page:18-24
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Lee Chee Khoon,Lord Sarah,Grunewald Tami,Gebski Val,Hardy-Bessard Anne-Claire,Sehouli Jalid,Woie Kathrine,Heywood Mark,Schauer Christian,Vergote Ignace,Scambia Giovanni,Ferrero Annamaria,Harter Philipp,Pujade-Lauraine Eric,Friedlander Michael

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference29 articles.

1. The role of surgery in the management of ovarian cancer: primary and interval cytoreductive surgery;Boente;Semin Oncol,1998

2. Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients;Sehouli;J Surg Oncol,2010

3. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma;Eisenkop;Cancer,2000

4. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?;Zang;Cancer,2004

5. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial;Harter;Ann Surg Oncol,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overall survival in ovarian cancer patients after cytoreductive surgery. A systematic review and meta-analysis;Current Problems in Surgery;2024-09

2. Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer;Current Cancer Drug Targets;2024-07

3. Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial);Annals of Surgical Oncology;2023-12-15

4. Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis;Diagnostics;2023-11-20

5. Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer;Cancers;2023-09-28